scispace - formally typeset
L

Leslee J. Shaw

Researcher at Cornell University

Publications -  871
Citations -  70793

Leslee J. Shaw is an academic researcher from Cornell University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 116, co-authored 808 publications receiving 61598 citations. Previous affiliations of Leslee J. Shaw include Saint Louis University & Cedars-Sinai Medical Center.

Papers
More filters
Journal ArticleDOI

Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy

TL;DR: LV functional parameters determined by gated FDG PET have incremental prognostic value over viability information in patients with ischemic cardiomyopathy, and data suggest that patients with residual viability and advanced cardiac remodeling are at high clinical risk.
Journal ArticleDOI

Proceedings from the Scientific Symposium: Sex Differences in Cardiovascular Disease and Implications for Therapies

TL;DR: CVD repair strategies should ideally be tested first in females to have the best chance of success for proof-of-concept, and sex-specific pharmacogenomic studies should be included in pharmacological development.
Journal ArticleDOI

Tracking atherosclerosis regression: a clinical tool in preventive cardiology.

TL;DR: Athrosclerosis imaging modalities such as coronary computed tomography, carotid ultrasound, cardiovascular magnetic resonance imaging, and intravascular ultrasound each possess specific imaging abilities and inter-test characteristics that enable their serial use as intermediate endpoints in clinical trials and, increasingly, in individual patient management.
Journal ArticleDOI

Impact of Coronary Artery Calcium Progression and Statin Therapy on Clinical Outcome in Subjects With and Without Diabetes Mellitus

TL;DR: CAC progression was greater and event-free survival lower in patients with DM compared to controls in proportion to the extent of CAC progression, suggesting that CAC progressions is an independent predictor of all-cause mortality in subjects with diabetes mellitus.